Cost assessment of treatment of acute myocardial infarction and angiographically visible coronary thrombus

Study was aimed to assess the real-world costs of manual thrombectomy (MT) in selected ST-segment elevation myocardial infarction patients with intracoronary thrombus (IT). Study group (IT+) comprised 51 patients with MT applied and control group (IT-) comprised 56 patients without IT who underwent...

Full description

Saved in:
Bibliographic Details
Published in:Journal of comparative effectiveness research 2018-05, Vol.7 (5), p.471-481
Main Authors: Pigo, Katarzyna, Nowak-Radzik, Edyta, M y czak, Tomasz, Banasik, Grzegorz, Nowalany-Kozielska, Ewa, Tomasik, Andrzej
Format: Article
Language:English
Subjects:
intracoronary thrombus
primary angioplasty
ST-segment elevation myocardial infarction
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Study was aimed to assess the real-world costs of manual thrombectomy (MT) in selected ST-segment elevation myocardial infarction patients with intracoronary thrombus (IT). Study group (IT+) comprised 51 patients with MT applied and control group (IT-) comprised 56 patients without IT who underwent angioplasty alone. Costs comprised hospital care and cost of disposable materials used during primary angioplasty. Complex management of patients with IT is more expensive, though allows to achieve clinical outcomes comparable to low-risk ST-segment elevation myocardial infarction patients without IT. A complex pharmaco-interventional strategy, with glycoprotein IIB/IIIA inhibitor and MT, though more expensive, may prove cost-effective.
ISSN:2042-6305
2042-6313
DOI:10.2217/cer-2017-0094